BioCentury
ARTICLE | Financial News

Laguna raises $30M in B round

February 18, 2015 1:37 AM UTC

Laguna Pharmaceuticals Inc. (La Jolla, Calif.) raised $30 million in a series B round led by new investors Versant Ventures and Frazier Healthcare. New investor BioMed Ventures and existing investor Sante Ventures also participated. Formerly known as ChanRx Inc., Laguna also moved its headquarters to La Jolla from Cleveland.

The company plans to start Phase III testing this year of vanoxerine, an oral inhibitor of potassium channel Kv11.1 ( KCNH2; hERG), to treat atrial fibrillation (AF) and atrial flutter. ...